Shaolin Capital Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,000
Closed -$13.8K 577
2026
Q1
$13.8K Sell
50,000
-25,000
-33% -$7.08K ﹤0.01% 485
2025
Q4
$15.2K Buy
75,000
+10,000
+15% +$1.72K ﹤0.01% 396
2025
Q3
$13.6K Sell
65,000
-35,000
-35% -$6.57K ﹤0.01% 318
2025
Q2
$19.3K Hold
100,000
﹤0.01% 258
2025
Q1
$18.6K Sell
100,000
-24,820
-20% -$5.98K ﹤0.01% 168
2024
Q4
$30K Sell
124,820
-100,180
-45% -$24.2K ﹤0.01% 161
2024
Q3
$33.8K Sell
225,000
-185,755
-45% -$19.2K ﹤0.01% 149
2024
Q2
$29.2K Sell
410,755
-221,245
-35% -$16.1K ﹤0.01% 200
2024
Q1
$22.1K Hold
632,000
﹤0.01% 230
2023
Q4
$17.8K Hold
632,000
﹤0.01% 303
2023
Q3
$38K Buy
+632,000
New +$33.6K ﹤0.01% 325
2023
Q2
Sell
-632,000
Closed -$29.6K 721
2023
Q1
$30K Buy
632,000
+92,000
+17% +$5.95K ﹤0.01% 504
2022
Q4
$30K Hold
540,000
﹤0.01% 526
2022
Q3
$54K Buy
+540,000
New +$44.9K ﹤0.01% 566

Other funds holding SBCWW

Shaolin Capital Management's SBCWW Position: Q2 2026 in Review

Shaolin Capital Management sold out of SBC Medical Group Warrants (SBCWW) in Q2 2026, closing a stake of 50,000 shares — an estimated $13.8K sold.

Shaolin Capital Management first reported a position in SBCWW in Q3 2022 and held it in 14 quarters. The position peaked at $54K in Q3 2022. 17 funds tracked by Wall St. Rank hold SBCWW as of Q2 2026.

  • Shaolin Capital Management reported no remaining SBC Medical Group Warrants position as of Q2 2026 after selling out during the quarter.
  • Shaolin Capital Management sold 50,000 SBC Medical Group Warrants shares in Q2 2026, an estimated $13.8K.
  • Shaolin Capital Management first reported a position in SBC Medical Group Warrants in Q3 2022 and held it in 14 quarters.
  • Shaolin Capital Management's SBC Medical Group Warrants position peaked at $54K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.